Sign in
Taking peopleNo phase

Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage (EMINENT-ICH)

Key facts

Who runs it
University Hospital, Basel, Switzerland
Where
Switzerland10 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
200 people, planned
Started
1 Jan 2024
Expected to end
Dec 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Early minimally invasive image guided endoscopic hematoma evacuation
  • Best medical treatment (BMT)
Record updated
22 July 2024

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Spontaneous supratentorial intracerebral hemorrhage (SSICH), defined as the sudden occurrence of bleeding into the lobar parenchyma and/or into the basal ganglia and/or thalamus that may extend into the ventricles confirmed by imaging
  • SSICH volume ≥20 mL <100 mL
  • A focal neurological deficit consisting of either; clinically relevant hemiparesis (≥4 motor points on the NIHSS for facial palsy, motoric upper and lower extremities combined); clinically relevant motor or sensory aphasia (≥2 points on the NIHSS); clinically relevant hemi-inattention (formerly neglect, 2 points on the NIHSS); decreased level of consciousness (Glasgow Coma Scale (GCS)≤13)
  • Presenting GCS 5 - 15 (in intubated patients GCS assessment will be performed after Rutledge et al. or if impossible, the last pre-intubation GCS will be used)
  • Endoscopic hematoma evacuation can be initiated within 24 hours after the patient was last seen well/symptom onset
  • Informed consent of patient or appropriate surrogate (for patients without competence)

Who cannot take part

  • Relevant disability prior to SSICH (mRS >2)
  • Infratentorial hemorrhage or midbrain extension/involvement of the hemorrhage
  • Any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 180 days (e.g. bilateral fixed dilated pupils)
  • Coagulation disorder (including anticoagulation) with an international normalized ratio (INR) of >1.5 which cannot be pharmacologically reverted until the planned time of evacuation
  • SSICH due to known or suspected structural abnormality in the brain (e.g. vascular malformation, aneurysm, arteriovenous malformation (AVM), brain tumor) and/or brain trauma and/or hemorrhagic conversion of an ischemic infarction
  • Multiple simultaneous intracranial hemorrhages (ICH) (e.g. multifocal ICH, chronic subdural hematoma (cSDH), acute subdural hematoma (aSDH), SAH)
  • Pregnancy

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is an open-labelled, single centre randomised controlled trial evaluating the efficacy of early minimally invasive image-guided hematoma evacuation in combination with the current best medical treatment compared to best medical treatment alone in improving functional outcome rates at 6 months after initial treatment in patients with spontaneous supratentorial intracerebral haemorrhage.

The 2 groups in the trial

  • Study InterventionTreatment being tested

    Early minimally invasive image guided endoscopic hematoma evacuation as an add-on therapy to BMT performed within 24 hours after SSICH symptom onset.

    Treatment: Early minimally invasive image guided endoscopic hematoma evacuation and Best medical treatment (BMT)

  • Control InterventionExisting treatment, for comparison

    Best medical treatment i.e. active blood pressure control, seizure prophylaxis and care as according to the current guidelines.

    Treatment: Best medical treatment (BMT)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage (EMINENT-ICH): a Randomized Controlled Trial
Fit questions
Built from NCT05681988, who can take part
Publications
Record updated
22 July 2024